Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

358.50
Delayed Data
As of Jul 01
 +9.27 / +2.65%
Today’s Change
329.09
Today|||52-Week Range
605.93
-33.96%
Year-to-Date
Wall Street set for best week since late 2014 as stocks rebound
Jul 01 / FT.com - Paid Partner Content
Forget Stem Cell Stocks: Here Are 3 Clinical-Stage Biotechs to Buy Instead
Jun 28 / MotleyFool.com - Paid Partner Content
Here's Why Regeneron Pharmaceuticals Inc Is Down 35% This Year
Jul 01 / MotleyFool.com - Paid Partner Content
3 Biotech Stocks to Buy Now for the Long Haul
Jun 25 / MotleyFool.com - Paid Partner Content
Esperion Therapeutics Inc Sinks After FDA Says, "Ask Us in 2019"
Jun 29 / MotleyFool.com - Paid Partner Content
Company News for June 23, 2016
Jun 23 / Zacks.com - Paid Partner Content
Pfizer's PCSK9 Inhibitor Tops Two Additional Phase III Studies
Jun 29 / Zacks.com - Paid Partner Content
Warren Buffett's Favorite High-Yield Dividend Stock
Jun 22 / MotleyFool.com - Paid Partner Content